211
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence and Associated Factors of Chronic Obstructive Pulmonary Disease Among Adults in Neno District, Malawi: A Cross-Sectional Analytical Study

ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , , , & show all
Pages 389-401 | Received 12 Oct 2023, Accepted 20 Jan 2024, Published online: 05 Feb 2024

References

  • Adeloye D, Basquill C, Papana A, Chan KY, Rudan I, Campbell H. An Estimate of the Prevalence of COPD in Africa: a Systematic Analysis. COPD. 2015;44(1):71–81. doi:10.3109/15412555.2014.908834
  • Ruvuna L, Sood A. Epidemiology of Chronic Obstructive Pulmonary Disease. Clin Chest Med. 2020;41(3):315–327. doi:10.1016/j.ccm.2020.05.002
  • Sti TA. Effect of education on self-efficacy of Turkish patients with chronic obstructive pulmonary disease. Patient Educ Counseling. 2004;55:114–120. doi:10.1016/j.pec.2003.08.006
  • Meghji J, Nadeau G, Davis KJ, et al. Noncommunicable lung disease in sub-Saharan Africa a community-based cross-sectional study of adults in urban Malawi. Am J Respir Crit Care Med. 2016;194(1):67–76. doi:10.1164/rccm.201509-1807OC
  • WHO. Chronic obstructive pulmonary disease (COPD). Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed July 21, 2023.
  • Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2023;61(4):2300239. doi:10.1183/13993003.00239-2023
  • Beran D, Zar HJ, Perrin C, Menezes AM, Burney P. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. 2015;3(2):159–170. doi:10.1016/S2213-2600(15)00004-1
  • Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet. 2015;385(9979):1778–1788. doi:10.1016/S0140-6736(15)60647-X
  • Gemert FV, Kirenga B, Chavannes N, et al. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study. Lancet Glob Health. 2015;3(1):e44–e51. doi:10.1016/S2214-109X(14)70337-7
  • van Gemert F, van der Molen T, Jones R, Chavannes N. The impact of asthma and COPD in sub-Saharan Africa. Prim Care Respir J. 2011;20(3):240–248. doi:10.4104/pcrj.2011.00027
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report GOLD Executive Summary. Am J Respir Critical Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Bahtouee M, Maleki N, Nekouee F. The prevalence of chronic obstructive pulmonary disease in hookah smokers. Patient Educ Counseling. 2018:7.doi10.1177/1479972317709652
  • Buist AS, Mcburnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
  • Musafiri S, Meerbeeck JV, Musango L, et al. Prevalence of atopy, asthma and COPD in an urban and a rural area of an African country. Respir Med. 2011;105(11):1596–1605. doi:10.1016/j.rmed.2011.06.013
  • National Statistical Office. http://www.nsomalawi.mw/index.php?option=com_content&view=article&id=134%3Apopulation-projections-for-malawi&catid=8&Itemid=3 Accessed 25 January, 2024.
  • Counted BE, No L, Behind ONE. 2018 Malawi Population And Housing Census. Lilongwe: Malawi National Statistics Office; 2019.
  • Rylance S, Jewell C, Naunje A, et al. communicable respiratory disease and air pollution exposure in Malawi: a prospective cohort study. Thorax. 2020;75(3):220–226. doi:10.1136/thoraxjnl-2019-213941
  • National Statistical Office. Population Projections 2018-2050. 2020:1–276
  • The DHS Program - Malawi: DHS, 2015-16 - Final Report (English). Available from: https://dhsprogram.com/publications/publication-fr319-dhs-final-reports.cfm. Accessed September 27, 2023.
  • Magitta F, Walker RW, Apte K, et al. Prevalence, Risk Factors and Clinical Correlates of COPD in a Rural Setting in Tanzania. Eur Respir J. 2018:51. doi:10.1183/13993003.00182-2017
  • Andreeva E, Lebedev A, Lebedev A, Moiseeva I, Kutznetsova O, Degryse J-M. The Prevalence of Chronic Obstructive Pulmonary Disease by the Global Lung Initiative Equations in North-Western Russia. Respir Int Rev Thoracic Dis. 2016;91(1):43–55. doi:10.1159/000442887
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:763.
  • Rajkumar P, Pattabi K, Vadivoo S, et al. A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods. Lancet. 2017:1–6. doi:10.1136/bmjopen-2016-015211
  • Ermatology D, Martínez-Mesa J, González-chica DA, Duquia RP, Duquia RP. Sample size: how many participants do I need in my research ?*. Anais brasileiros de dermatologia. 2014;89(4):609–615. doi:10.1590/abd1806-4841.20143705
  • Charan J, Biswas T. Review Article How to Calculate Sample Size for Different Study Designs in Medical Research ? Indian J Psychological Med. 2013;35(2):121–126. doi:10.4103/0253-7176.116232
  • Saleh S, van Zyl-Smit R, Allwood B, et al. Questionnaires for Lung Health in Africa across the Life Course. Int J Environ Res Public Health. 2018;15(8):1615. doi:10.3390/ijerph15081615
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. The European Respiratory Journal. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
  • Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST
  • Woldeamanuel GG, Mingude AB, Geta TG. Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study. BMC Pulm Med. 2019;19(1):181. doi:10.1186/s12890-019-0946-z
  • Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD. 2006;3(2):95–100. doi:10.1080/15412550600651552
  • Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009;34(3):588–597. doi:10.1183/09031936.00164608
  • Awokola BI, Amusa GA, Jewell CP, et al. Chronic obstructive pulmonary disease in sub-Saharan Africa. Int J Tuberc Lung Dis off J Int Union Tuberc Lung Dis. 2022;26(3):232–242. doi:10.5588/ijtld.21.0394
  • Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi:10.1016/S2213-2600(21)00511-7
  • Nightingale R, Lesosky M, Flitz G, et al. Noncommunicable Respiratory Disease and Air Pollution Exposure in Malawi (CAPS). A Cross-Sectional Study. Am J Respir Crit Care Med. 2019;199(5):613–621. doi:10.1164/rccm.201805-0936OC
  • Magitta NF, Walker RW, Apte KK, et al. Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania. Eur Respir J. 2018;51(2):1700182. doi:10.1183/13993003.00182-2017
  • Adhikari TB, Acharya P, Högman M, et al. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: findings from a Community-based Household Survey. Int J Chron Obstruct Pulmon Dis. 2020;15:2319–2331. doi:10.2147/COPD.S268110
  • Ale BM, Ozoh OB, Gadanya MA, et al. Estimating the prevalence of COPD in an African country: evidence from southern Nigeria. J Glob Health Rep. 2022:6:e2022049. doi:10.29392/001c.38200
  • North CM, Kakuhikire B, Vor D, et al. Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study. Int J Med. 2019;9(1):1–11. doi:10.7189/jogh.09.010434
  • Halpin DMG, Celli BR, Criner GJ, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019;23(11):1131–1141. doi:10.5588/ijtld.19.0397
  • Menezes A, Jardim J, Perez Padilla R, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saúde Pública Minist Saúde Fundação Oswaldo Cruz Esc Nac Saúde Pública. 2005;21:1565–1573. doi:10.1590/S0102-311X2005000500030
  • Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S146390
  • Sutradhar I, Das Gupta R, Hasan M, Wazib A, Sarker M. Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in Bangladesh: a Systematic Review. Cureus. 2019;11(1):e3970. doi:10.7759/cureus.3970
  • Alam DS, Chowdhury MA, Siddiquee AT, Ahmed S, Clemens JD. Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in Bangladesh. COPD J Chronic Obstr Pulm Dis. 2015;12(6):658–667. doi:10.3109/15412555.2015.1041101
  • Nugmanova D, Feshchenko Y, Iashyna L, et al. The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study. BMC Pulm Med. 2018;18(1):26. doi:10.1186/s12890-018-0589-5
  • Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax. 2006;61(6):472–477. doi:10.1136/thx.2005.052449
  • Ito K, Barnes PJ. COPD as a Disease of Accelerated Lung Aging. Chest. 2009;135(1):173–180. doi:10.1378/chest.08-1419
  • Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
  • Fan H, Wu F, Liu J, et al. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ann Transl Med. 2021;9(5):390. doi:10.21037/atm-20-4576
  • Yakar HI, Gunen H, Pehlivan E, Aydogan S. The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:323–329. doi:10.2147/COPD.S116086
  • Lee CH, Lee MC, Lin HH, et al. Pulmonary Tuberculosis and Delay in Anti-Tuberculous Treatment Are Important Risk Factors for Chronic Obstructive Pulmonary Disease. PLoS One. 2012;7(5):e37978. doi:10.1371/journal.pone.0037978
  • Lam H, Jiang CQ, Jordan RE, et al. Prior TB, Smoking, and Airflow Obstruction: a Cross-Sectional Analysis of the Guangzhou Biobank Cohort Study. Chest. 2010;137(3):593–600. doi:10.1378/chest.09-1435
  • Guo Y, Xing Z, Shan G, et al. Prevalence and Risk Factors for COPD at High Altitude: a Large Cross-Sectional Survey of Subjects Living Between 2100–4700 m Above Sea Level. Front Med. 2020;7. doi:10.3389/fmed.2020.581763
  • Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respir Int Rev Thorac Dis. 2013;86(1):76–85. doi:10.1159/000350917
  • Daldoul H, Denguezli M, Jithoo A, et al. Prevalence of COPD and tobacco smoking in Tunisia--results from the BOLD study. Int J Environ Res Public Health. 2013;10(12):7257–7271. doi:10.3390/ijerph10127257
  • Global Tobacco Control Information & Statistics I Tobacco Atlas. Tobacco Atlas. Available from: https://tobaccoatlas.org/. Accessed July 18, 2023.
  • Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Kyaw Soe NM. Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2017;12:1915–1922. doi:10.2147/COPD.S138304
  • WHO global report on trends in prevalence of tobacco use 2000-2025, third edition. Available from: https://www.who.int/publications-detail-redirect/who-global-report-on-trends-in-prevalence-of-tobacco-use-2000-2025-third-edition. Accessed July 18, 2023.
  • Kadzamira MA, Gausi HJ, Phiri T. The socio-economic impact of disease burden due to smoking in Malawi. 2021.
  • Vellios N, Ross H, Perucic AM. Trends in cigarette demand and supply in Africa. PLoS One. 2018;13(8):e0202467. doi:10.1371/journal.pone.0202467
  • Peer N. Current strategies are inadequate to curb the rise of tobacco use in Africa. S Afr Med J. 2018;108(7):551. doi:10.7196/SAMJ.2018.v108i7.12978
  • Njoroge MW, Mjojo P, Chirwa C, et al. Changing lung function and associated health-related quality-of-life: a five-year cohort study of Malawian adults. eClinicalMedicine. 2021;41:101166. doi:10.1016/j.eclinm.2021.101166
  • Asamoah-Boaheng M, Acheampong L, Tenkorang EY, Farrell J, Oyet A, Midodzi WK. Association between early history of asthma and COPD diagnosis in later life: a systematic review and meta-analysis. Int J Epidemiol. 2018;47(6):1865–1876. doi:10.1093/ije/dyy207
  • Mart MF, Peebles RS. Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome. Curr Opin Immunol. 2020;66:161–166. doi:10.1016/j.coi.2020.10.006
  • Banda HT, Thomson R, Mortimer K, et al. Community prevalence of chronic respiratory symptoms in rural Malawi: implications for policy. PLoS One. 2017;12(12):1–13. doi:10.1371/journal.pone.0188437
  • Morgan BW, Grigsby MR, Siddharthan T, et al. Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries. J Allergy Clin Immunol. 2019;143(4):1598–1606. doi:10.1016/j.jaci.2018.06.052
  • Hosseini M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis. Respir Res. 2019;20(1):229. doi:10.1186/s12931-019-1198-4
  • Awokola BI, Amusa GA, Jewell C, et al. Chronic Obstructive Pulmonary Disease (COPD) in Sub-Saharan Africa: a Systematic Review and Meta-Analysis. In: TP65. TP065 ENVIRONMENTAL EXPOSURES AND LUNG DISEASE. American Thoracic Society; 2021:A3133–A3133. doi:10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A3133.
  • Hu G, Zhou Y, Tian J, et al. Risk of COPD From Exposure to Biomass Smoke: a Metaanalysis. Chest. 2010;138(1):20–31. doi:10.1378/chest.08-2114
  • Pathak U, Gupta NC, Suri JC. Risk of COPD due to indoor air pollution from biomass cooking fuel: a systematic review and meta-analysis. Int J Environ Health Res. 2020;30(1):75–88. doi:10.1080/09603123.2019.1575951
  • Viramgami A, Sheth A, Bagepally BS, Balachandar R. Study on the Association between Domestic Biomass Fuel Exposure and Pulmonary Function: a Systematic Review and Meta-Analysis. SSRN Electronic Journal. 2022. doi:10.2139/ssrn.4267517
  • Amaral AFS, Patel J, Kato BS, et al. Airflow Obstruction and Use of Solid Fuels for Cooking or Heating: BOLD Results. Am J Respir Crit Care Med. 2018;197(5):595–610. doi:10.1164/rccm.201701-0205OC
  • Ortiz-Quintero B, Martínez-Espinosa I, Pérez-Padilla R. Mechanisms of Lung Damage and Development of COPD Due to Household Biomass-Smoke Exposure: inflammation, Oxidative Stress, MicroRNAs, and Gene Polymorphisms. Cells. 2023;12(1):67. doi:10.3390/cells12010067
  • Camp PG, Ramirez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smoke versus tobacco smoke-exposed Mexican women. Eur Respir J. 2014;43(3):725–734. doi:10.1183/09031936.00206112
  • D’Ascanio M, Viccaro F, Calabrò N, et al. Assessing Static Lung Hyperinflation by Whole-Body Plethysmography, Helium Dilution, and Impulse Oscillometry System (IOS) in Patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:2583–2589. doi:10.2147/COPD.S264261
  • Aron MB, Connolly E, Vrkljan K, et al. Attitudes toward COVID-19 Vaccines among Patients with Complex Non-Communicable Disease and Their Caregivers in Rural Malawi. Vaccines. 2022;10(5):792. doi:10.3390/vaccines10050792
  • Jain NK. Chronic obstructive pulmonary disease and tuberculosis. Lung India off Organ Indian Chest Soc. 2017;34(5):468–469. doi:10.4103/lungindia.lungindia_183_17